Matthew Trudeau
Keine laufenden Positionen mehr
Profil
Matthew Trudeau worked as the Head of the U.S.
Business Team at Bluebird Biosciences, Inc. from 2016 to 2021.
He also worked as the Chief Commercial Officer at Vascular Biogenics Ltd.
in 2022.
Prior to his professional experience, he obtained an undergraduate degree from Colby College and a graduate degree from Northeastern University.
Ehemalige bekannte Positionen von Matthew Trudeau
| Unternehmen | Position | Ende |
|---|---|---|
| NOTABLE LABS, LTD. | Corporate Officer/Principal | 01.08.2022 |
| Bluebird Biosciences, Inc. | Corporate Officer/Principal | 01.01.2021 |
Ausbildung von Matthew Trudeau
| Colby College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| Bluebird Biosciences, Inc. | |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
